CODX

Co-Diagnostics (CODX)

About Co-Diagnostics (CODX)

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$0.76

Daily low

$0.72

Price at open

$0.73

52 Week High

$2.23

52 Week Low

$0.70

Market cap

23.3M

Dividend yield

0.00%

Volume

170,869

Avg. volume

187,887

P/E ratio

-.54

Co-Diagnostics News